Follow-Up Study of a Multiple Myeloma Patient Successfully Treated with Clarithromycin (CAM), Low-Dose Lenalidomide and Low-Dose Dexamethasone: Significance and Possible Mechanism of Action of CAM as an Add-On Therapy
Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52649#.VJzPNcCAM4 Author(s) Nobuo Takemori 1 , Toshio Fukuda 2 , Masaru Kojima 3 Affiliation(s) 1 Division of Hematology, Internal Medicine, Imai Hospital, Ashikaga, Japan . 2 Graduate School of Health Sciences, Gunma University, Maebashi, Japan . 3 Department of Anatomic and Diagnostic Pathology, Dokkyo Medical University School of Medicine, Shimotsuga-gun, Japan . ABSTRACT Background: Recently, high efficacy of the chemotherapeutic regimen combining clarithromycin (CAM) with lenalidomide (Len) and dexamethasone (Dex) (BiRD) in treating multiple myeloma (MM) patients has been reported. However, the exac...